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Abstract
Signaling events affecting thymic selection of un-manipulated polyclonal natural CD25
+foxp3
+ regulatory T cells (nTreg)
have not been established ex vivo. Here, we report a higher frequency of phosphorylated STAT-5 (pSTAT-5) in nTreg cells in
the adult murine thymus and to a lesser extent in the periphery, compared to other CD4
+CD8
2 subsets. In the neonatal
thymus, the numbers of pSTAT-5
+ cells in CD25
+foxp3
2 and nTreg cells increased in parallel, suggesting that pSTAT-
5
+CD25
+foxp3
2 cells might represent the precursors of foxp3
+ regulatory T cells. This ‘‘specific’’ pSTAT-5 expression
detected in nTreg cells ex vivo was likely due to a very recent signal given by IL-2/IL-15 cytokines in vivo since (i) it
disappeared rapidly if cells were left unstimulated in vitro and (ii) was also observed if total thymocytes were stimulated in
vitro with saturating amounts of IL-2 and/or IL-15 but not IL-7. Interestingly, STAT-5 activation upon IL-2 stimulation
correlated better with foxp3 and CD122 than with CD25 expression. Finally, we show that expression of an endogenous
superantigen strongly affected the early Treg cell repertoire but not the proportion of pSTAT-5
+ cells within this repertoire.
Our results reveal that continuous activation of the CD122/STAT-5 signaling pathway characterize regulatory lineage
differentiation in the murine thymus.
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Introduction
Natural regulatory CD4
+CD25
+foxp3
+ T cells (nTreg) are
generated in the thymus of mice and humans early in their
ontogeny [1,2,3]. These nTreg cells are in charge of controlling
peripheral T cells that have escaped negative selection in the
thymus and that could pose a threat to the integrity of healthy
tissues. The importance of the transcription factor Foxp3 for
controlling auto-immunity in humans is best exemplified in
patients suffering from the IPEX (Immunodysregulation, Poly-
endocrinopathy, and Enteropathy, X-linked) syndrome, who
develop a potentially lethal autoimmune syndrome and that carry
mutations in the Foxp3 gene [4]. Furthermore, ectopic expression
of foxp3 confers suppressive function to murine naı ¨ve T cells [5]
whereas ablation of foxp3 in nTreg cells leads to severe
autoimmunity [6,7]. Similar cases of autoimmunity have been
found in nTreg cells that have spontaneously lost foxp3 expression
[8]. Thus, a better understanding of foxp3 regulation is needed for
translating the huge therapeutic potential of nTreg cells to the
clinic.
Signaling pathways that lead immature thymic progenitors to
differentiate into foxp3-expressing cells began to be elucidated
(recently reviewed in [9]). Strong experimental evidence point to a
crucial role of the TCR signal in nTreg cell ‘‘commitment’’ in the
thymus and notably of CARMA-1 [10,11] and LAT [12]
molecules. From TCR transgenic studies, it also appears that a
higher affinity (and thus, presumably a higher signal) perceived by
an immature T cell ultimately impacts on regulatory commitment,
at least in terms of frequencies of CD4
+CD25
+ cells [13]. This
enrichment in nTreg cell differentiation of antigen-specific cells
upon encounter with the cognate antigen in the thymus was also
observed for some [14] but not all [15,16] specificities. The reason
for the discrepancy in the results might be due to the existence of a
‘‘niche’’ for nTreg cell differentiation in the thymus. It was indeed
elegantly shown that the size of the available nTreg ‘‘niche’’ is as
important as the affinity of the TCR itself for efficient nTreg cell
maturation [17,18].
Besides TCR signals, cytokines have also been proposed to play
an important role in nTreg cell ‘‘commitment’’ in the thymus.
Before the identification of foxp3 as the most reliable marker for
regulatory T cells, it was already noticed that CD4
+CD25
+ T cells
presented a peculiar response to IL-2 signaling [19]. Studies using
genetically deficient mice have expanded our knowledge on the
role of IL-2 signaling in foxp3 expression but several caveats
remain. Deletion of the ß chain of the interleukin-2 receptor
(CD122) (which comprises two additional units CD25 and CD132
(IL-2R-gc)) resulted in a complete absence of foxp3
+ cells in the
thymus in some [20,21], but not all studies [22]. In contrast to
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have a dramatic decrease in total number of T cells and a quasi-
absence of foxp3
+ cells [22]. Interestingly, a lack of foxp3
+ cells
was also observed in mice doubly-deficient for IL-2 and IL-15 (a
cytokine that share CD122 and CD132 with IL-2) [20], suggesting
that foxp3 expression in the thymus of IL-2-KO animals observed
in earlier studies [22,23] could be due to a compensatory action of
IL-15. In that respect, a role for IL-15 in directing foxp3
expression in human cells has recently been proposed [24]. A
further support for a role of IL-2 in driving foxp3 expression came
from studies showing that enforced expression of STAT-5, a
transcription factor downstream of CD122 and known to drive
foxp3 expression [20,25], leads to enhanced nTreg cell generation
in the thymus [26,27]. Based on these data and others [28], the
current model of nTreg differentiation in the thymus postulate a
two-step pathway in which TCR and co-stimulatory signals
generate CD25
+foxp3
2 precursor cells, followed by a gc-mediated
cytokine signal allowing full expression of foxp3 and generation of
mature CD25
+foxp3
+ bona fide nTreg cells.
Here, we characterize the expression of pSTAT-5 in
CD25
+foxp3
+ cells, either in a static view in adult mice, or in a
more dynamic perspective during nTreg generation in the
neonates or during negative selection induced by an endogenous
Sag. Our results suggest that activation of the STAT-5 signaling
pathway may play a more complex role during nTreg differen-
tiation than the mere induction of foxp3 expression.
Materials and Methods
Mice
C57BL/6J Ly5.2 female mice and DBA/2 male mice were
purchased from Janvier laboratories (Le Genest Saint Isle, France).
C57BL/66DBA/2 F1 or C57BL/6 neonates were generated in
our animal facility. All animals were kept under specific pathogen-
free conditions and manipulated according to European council
directive 86/609/EEC. The study was approved by the Regional
Ethical Comittee 3 of Ile-de-France (ref p3/2008/039).
Flow cytometry analysis
C57BL/66DBA/2 F1 or C57BL/6 neonates were sacrificed on
ice and their thymus was removed. Adult mice were sacrificed by
cervical dislocation. After mechanical dissociation and trypan blue
exclusion counts, 10
6 cells were labeled with 100 ml of a mix of
mAbs diluted in PBS containing 3% FCS for 30 minutes at 6–8uC
in the dark. When needed, biotin-labeled mAb against TCR were
used alone, followed by a mix containing the FITC-labeled
streptavidine and the other mAbs. Intracellular staining using
foxp3 mAb was performed according to the kit manufacturer’s
instructions (eBioscience). For pSTAT-5 detection, cell suspensions
were rapidly fixed after sacrifice or after in vitro culture in
10 volumes of a solution of PBS 1.5% formaldehyde for
10 minutes at room temperature. Cells were then washed in a
solution of PBS containing 0.2% of BSA, and permeabilized with
100% methanol for 10 minutes on ice. After extensive washing
with PBS 0.2% BSA, cells were incubated with the phospho-
specific mAb in combination with the mAbs of interest for
30 minutes in the dark at room temperature. In some experiments,
a pSTAT-5 (Y694) blocking peptide (AKAVDGpYVKPQIKQV)
was used as a negative control (fig. S1). Otherwise, the pSTAT5
negative threshold was defined on unstimulated cells or on cells
stained with all flurorescent antibodies minus pSTAT5. At least
100,000 events were collected on a FACS LSR II (Becton
Dickinson, San Jose, CA). Data were analyzed using FlowJo
software (TreeStar, Ashland, OR).
In vitro cytokine stimulation
Cells from the thymus or from the spleen of C57BL/6 adult
mice were stimulated in RPMI 1640 (InVitrogen, Cergy-Pontoise,
France) supplemented with 10% FCS, 2 mM glutamine, 100 U/
ml penicillin, 100 mg/ml streptomycin, 50 mM b-Mercaptoethanol
and 10 mM HEPES with cytokines at 50 ng/ml of murine
recombinant IL-15 (Peprotech, Paris, France) or 50 ng/ml human
recombinant IL-7 (Miltenyi Biotec, Paris, France), or 10 to 50 ng/
ml of murine recombinant IL-2 (Peprotech) for 30 to 60 minutes
in a 37uC, 5% CO2 incubator. At the end of incubation, cell
suspensions were fixed in 10 volumes of PBS 1.5% formaldehyde
for flow cytometry analysis.
Antibodies
The following mAbs and reagents were used for phenotypic and
repertoire analysis: peridinin-chlorophyll-protein (PercP)-, Alexa
fluor 700- or Pacific blue-labeled anti-CD4 (RM4-5, Becton
Dickinson (BD), San Diego, CA), PercP-labeled anti CD8 (53-6.7,
BD), Alexa fluor 700-labeled anti-CD8 (53-6.7, eBioscience, San
Diego, CA, USA), PE-Alexa Fluor 610-conjugated anti-CD8 (53-
6.7, Caltag Laboratories, Burlingame, CA, USA), PE-Cyanin 7-
conjugated anti-CD25 (PC61, eBioscience), biotinylated and PE-
labeled anti-CD122 (TMß1, BD), Pacific Blue-, eFluor 450- or
Alexa fluor 700-labeled anti-foxp3 (FJK16s, eBioscience), PE- and
biotin-labeled anti-BV6 (RR4-7, BD), PE- and biotin-labeled anti-
BV11 (RR3-15, BD), PE- and biotin-labeled anti BV8.1/8.2
(MR5-2, BD), FITC- and PE-labeled streptavidine (BD). Alexa
fluor 488- and Alexa fluor 647-labeled anti-pSTAT-5 (Y694) were
from BD.
Statistical analyses
Two-tailed unpaired t test with 95% confidence intervals were
performed using GraphPad Prism version 5.0 for PC (GraphPad
Software, San Diego, CA). Mean values were considered
statistically different if the p value was below 0.05.
Results
Preferential STAT-5 phosphorylation in foxp3
+ cells in
adult mice
To investigate the association between pSTAT-5 and foxp3
expression inadultmice, we quantified the frequencies of pSTAT-5
+
cells in various CD4
+ subsets defined by CD25 and foxp3 expression
inthe thymusandintheperipheryofadultC57BL/6 mice (fig.1).In
an attempt to preserve fleeting phosphorylation events occurring in
vivo, we fixed freshly isolated thymocytes with formaldehyde (FA) few
minutes after sacrifice. Cell suspensions were then stained with the
antibodies detecting the CD4, CD8, CD25, foxp3 molecules and the
phosphorylated form of STAT-5 at a Y in position 694. The
specificity of the staining was validated using a pSTAT-5 blocking
peptide, either on freshly isolated cells (fig S1A) or in vitro on IL-2-
stimulated cells (fig S1B). A faint staining was detected for pSTAT-5
on freshly isolated FA-treated CD4
+CD8
2 thymocytes, mainly in
foxp3
+ cells (fig. 1A). We observed that the frequencies of pSTAT-5
+
cells were the highest in CD25
+foxp3
+ cells, where up to 20% of the
cells expressed pSTAT-5 (fig. 1B). The other subsets in which
pSTAT-5 could be detected were CD25
2foxp3
+ and CD25
+foxp3
2
cells which bared a similar proportion of pSTAT-5+ cells.Of note,
the median fluorescence intensities of pSTAT5 did not differ among
the varioussubsetsanalyzed (figS1C). Verylow frequencies(,0.1%)
of pSTAT-5
+ cells were observed in CD25
2foxp3
2 cells, which
comprise the majority of CD4
+CD8
2 cells of the thymus. Likewise,
pSTAT-5
+ cells were present in greater frequencies in CD25
+foxp3
+
cells in the peripheral lymph nodes albeit at much lower frequencies
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might be that the total amount of STAT5 molecules differs in the
variousCD4 subsets defined byCD25and foxp3 expression. To rule
out this possibility, we measured the expression of STAT5 by flow
cytometry in the various CD4 subsets in the thymus. Our results
clearly show that STAT5 was homogeneously expressed and at
similar levels in all the CD4+ subsets analyzed (fig S1), directly
showing that the increased proportion of pSTAT5+ in
CD4+CD25+foxp3+ cells was not due to a higher proportion of
STAT5+ cells in this subset. Altogether, these results demonstrate
directly for the first time that STAT-5 is preferentially phosphor-
ylated in vivo within CD4
+CD8
2CD25
+foxp3
+ cells of the murine
thymus.
Kinetics of pSTAT-5 and foxp3 expression in the neonatal
thymus
We then wanted to know whether pSTAT-5 and foxp3
expression would also be associated during early nTreg thymic
differentiation. We first assessed the appearance of CD25
+foxp3
2,
CD25
+foxp3
+ and CD25
2foxp3
+ subsets in the first 3 days of life
in normal C57BL/6 mice (B6) (fig. 2A–B). At all time points
analyzed, the CD25
+foxp3
2 cells represented the majority of the
analyzed subsets, in frequencies and in numbers (fig. 2A–B, white
bars). The numbers of CD25
+foxp3
2 cells were always higher than
the numbers of the CD25
+foxp3
+ cells (fig. 2B), suggesting that
only a fraction of CD25
+foxp3
2 cells may convert into
CD25
+foxp3
+ cells. We then analyzed pSTAT-5 expression in
these subsets (fig. 2C–D). We found a remarkably stable profile of
pSTAT-5 expression in terms of frequencies in the analyzed
subsets. More than 30% of CD25
+foxp3
+ cells expressed pSTAT-5
from birth, a slightly higher value than the one observed in adult
mice. This frequency tended to decrease after D1 of life (fig. 2C,
black bars), to reach similar values than the one observed in adult
mice (fig. 1B). Expression of pSTAT-5 in other subsets was less
abundant since it concerned less than 10% of the cells and no
significant changes occurred during the period analyzed (fig. 2C).
When numbers of pSTAT-5
+ cells were considered, we observed a
simultaneous increase in CD25
+foxp3
2 and in CD25
+foxp3
+ cells
in the first 3 days of life (fig. 2D), consistent with the hypothesis
that these two subsets are inter-related. Thus, our results show that
pSTAT-5 is closely associated with foxp3 acquisition in the murine
thymus early during ontogeny.
Preferential STAT-5 phosphorylation in foxp3
+
thymocytes in vitro correlates with CD122 but not CD25
expression
Interestingly, pSTAT-5 expression was detected at much lower
frequencies if cells from the thymus or from the periphery were
allowed to sit on ice for an hour before fixation and staining
(fig. 3A), showing that the results gathered on freshly isolated cells
likely reflected a very recent signal received in vivo. In an attempt to
identify a molecule responsible for such a signal, we cultured
Figure 1. Preferential phosphorylation of STAT-5 in foxp3
+ cells in adult C57BL/6 mice. (A) The gating strategy is indicated by the arrows.
Left panel: total thymocytes were stained with CD4 and CD8 antibodies. The indicated gate defines CD4
+CD8
2 cells. Middle panel: CD25 and foxp3
expression in CD4
+CD8
2 cells. Right panel: pSTAT-5 expression in CD25
+foxp3
+CD4
+CD8
2 cells. (B–C) Frequencies of pSTAT-5
+ cells within thymic
CD4
+CD8
2 cells of the indicated CD25/foxp3 phenotype in the thymus (B) and in the mesenteric lymph nodes (C) in 6- to 13- week-old mice. Each
dot represents a single mouse. Results are compiled from 4 to 11 independent experiments. The p values are indicated in each panel (***p,0.001;
*p,0.05; NS not significant).
doi:10.1371/journal.pone.0019038.g001
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STAT-5 through CD132. Remarkably, IL-2 or IL-15 (or a
combination of the two) preferentially activated STAT-5 in foxp3
+
cells, whether the cells expressed CD25 or not (fig. 3B).
Interestingly, CD25
2foxp3
+ but not CD25
+foxp3
2 cells were
highly susceptible to IL-2/IL-15 stimulation in vitro. Only 15–20%
of CD25
+foxp3
2 cells activated STAT-5 upon IL-2/IL-15
stimulation whereas 50–70% of CD25
2foxp3
+ cells were able to
activate STAT-5 in response to these cytokines. In contrast to IL-2
or IL-15, IL-7 induced a high proportion of pSTAT-5
+ cells in
conventional CD25
2foxp3
2 cells whereas this cytokine induced
pSTAT-5 only in a limited numbers of nTreg compared with Il-2
or Il-15 (fig. 3B). IL-4 and IL-21 did not induce STAT-5
phosphorylation on total thymocytes in our hands (data not
shown).
The higher proportion of pSTAT-5
+ cells in foxp3
+ cells upon
IL-2/IL-15 stimulation was most likely due to the higher levels of
CD122 expression on the surface of foxp3
+ cells compared to
foxp3
2 thymocytes (fig. 3C). Overall, CD25
+foxp3
+ cells had
almost two-fold more CD122 molecules expressed at the cell
surface than CD25
+foxp3
2 cells (fig. 3D). A similar pattern of
expression was observed for CD132, with the highest expression
found in foxp3
+ cells (data not shown). Thus, the results suggest
that IL-2 and/or IL-15 but not IL-7 are likely candidates for the
enriched pSTAT-5 expression in CD25
+foxp3
+ cells that we
detected ex vivo. They also show that foxp3 and CD122 but not
CD25 expression correlated with greater susceptibility to IL-2
signaling in vitro.
Enhanced selection of Mls-1
a–specific T cells into the
regulatory lineage in the thymus is not associated with
increased proportions of pSTAT-5
+ cells
Numerous studies in TCR transgenic mice have shown that
nTreg selectionis increased inthe settingwhereforcedexpression of
the cognate antigen is directed in the thymus. We thus wanted to
know whether negative selection of self-specificities within a
polyclonal repertoire would also be characterized by an increase
in selection of nTreg expressing the same specificity. For this, we
studied TCR-induced negative selection of BV6
+ T cells in the
neonatal thymus of C57BL/66DBA/2 F1 mice (B6D2) due to
recognition of the endogenous superantigen Mls-1
a [29]. As a
control, we quantified the frequencies of BV6
+ cells in the thymus of
neonatal B6 mice. As expected, the frequencies of BV6
+ T cells
determined in CD4
+CD8
2 cells of the thymus decreased 2.5-fold
during the first 10 days of life of B6D2 mice while the distribution of
other specificities within CD4
+CD8
2 cells remained stable (fig. S2).
We observed a marked increase in the frequencies of CD25
+foxp3
+
cells within Sag-reactive cells compared to the rest of the
BV6
2CD4
+CD8
2 thymocytes at day 3 after birth (fig. 4A). Overall,
Figure 2. Kinetics of pSTAT-5 expression during Treg cell differentiation in the neonatal thymus of C57BL/6 mice. (A–B) Frequencies
(A) and absolute numbers (B) of CD4
+CD8
2 cells of the indicated phenotype defined by CD25 and foxp3 expression in the thymus of C57BL/6
neonates at the indicated days after birth. For sake of clarity, analysis of CD25
2foxp3
2 cells which encompass .90% of all CD4
+ T cells, is not
included in the figure (C–D) Frequencies (C) and absolute numbers (D) of pSTAT-5
+ cells within CD4
+CD8
2 thymic subsets defined by CD25 and
foxp3 expression in C57BL/6 neonates at the indicated days after birth. The p values are indicated in each panel (***p,0.001; **p,0.01; *p,0.05; NS
not significant). Results shown are the compilation of 2 independent experiments with 6 to 8 mice analyzed per day. For sake of clarity, only the
p values comparing CD25
+foxp3
2 and CD25
+foxp3
+ cells are shown.
doi:10.1371/journal.pone.0019038.g002
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+foxp3
+ T cells in BV6
+ T cells were
increased at every time point compared to BV11
+CD4
+, BV8.1/
8.2
+CD4
+ or total CD4
+CD8
2 cells (fig. 4B). This increase was due
totheexpression oftheMls-1
a Sagsinceitwasnot observed inaged-
matched B6 mice (fig S3A–B)). These enhanced frequencies
translated in numbers of BV6
+ of the CD25
+foxp3
+ phenotype
that were comparable to other specificities unaffected by the Sag,
such as BV8+ cells (fig. 4B), showing that negative selection (as
definedby physical elimination) ofMls-1
a-specificTreg cells was not
apparent. A similar observation was made for nTreg ‘‘precursors’’
i.e CD25
+foxp3
2 cells, which presented higher frequencies of BV6
+
cells compared to other specificities in F1 mice (fig. 4D), or to BV6
+
cells of B6 mice (fig S3C). Likewise, these increased frequencies
translated into high numbers of these cells, equal to the numbers of
cells carrying other specificities (fig. 4E), again showing a lack of
physical depletion of Sag-specific cells at this stage. Remarkably, up
to 25%of CD25
+foxp3
+ cellscould be Mls-1
a-specificat day3 of life
of F1 mice. The Treg repertoire normalized thereafter (fig. S4).
Thus, our results demonstrate that early expression of the self-
antigen Mls-1
a resulted in negative selection of BV6
+CD4
+ cells
whereas nTreg of the same specificity appeared to ‘‘resist’’ this
process.
In order to determine whether the strength of the TCR signal
would impact on STAT-5 sensitivity, we analyzed whether more
BV6
+ cells would activate STAT-5 in response to the Sag. We did
not observe such a correlation: similar frequencies of pSTAT-5
+
cells were found in all CD4
+CD8
2 subsets defined by CD25 and
foxp3 expression when BV6
+ and BV6
2 cells were compared at
day 3 after birth (Table 1). Notably, a similar proportion of
CD25
+foxp3
+ cells expressed pSTAT-5 in BV6
+ and BV6
2 cells
although the overall proportion of CD25
+foxp3
+ cells was greatly
enhanced in BV6
+ cells (fig. 4B). Thus, the proportion of Sag-
specific nTreg cells activating STAT-5 was independent of the
selection of a greater number of cells into the regulatory lineage.
Discussion
Our results demonstrate that pSTAT-5 and foxp3 are closely
linked during CD4
+CD25
+foxp3
+ T cell differentiation in un-
manipulated mice. We show that pSTAT-5 is associated with
Figure 3. Preferential STAT-5 phosphorylation in foxp3
+ thymocytes in vitro correlates with CD122 expression. (A) Frequency of
pSTAT-5
+ cells in CD25
+foxp3
+CD4
+CD8
2 cells of the thymus and of the mesenteric lymph node (mLN) fixed with formaldehyde immediately after
sacrifice (0 min.) or after 60 minute incubation on ice (60 min.). (B) Frequency of pSTAT-5
+ cells in thymocytes of the indicated CD25/foxp3
phenotype after in vitro incubation with the indicated cytokines for 60 min. (Med; medium only). Results shown are compiled from 2 to 8
independent experiments. (C) Representative profile of CD122 expression in the indicated thymic subsets defined by CD25 and foxp3 expression.
Note the higher expression of CD122 in foxp3
+ cells (D) Median fluorescence intensity of CD122 expression in thymic subsets defined by CD25 and
foxp3 expression. Each dot represents a single mouse. Results shown are compiled from 2 independent experiments. The p values are indicated in
the figure (***p,0.001; **p,0.01).
doi:10.1371/journal.pone.0019038.g003
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cells in the first week of life. This association is however not as
simple as one might have predicted from the recent data showing a
role for STAT-5 in inducing foxp3 in the thymus and in the
periphery [27,28,30]. Notably, we did not find enrichment in the
frequency of pSTAT-5
+ cells in CD25
+foxp3
2 precursors of nTreg
cells during ontogeny, a result that would have been expected if
one postulate that STAT-5 activation precedes foxp3 expression.
Rather, we observed that pSTAT-5
+ cells represented only a
minor subset of CD25
+foxp3
2 precursors in frequency. Interest-
ingly, we found similar numbers of pSTAT-5
+CD25
+foxp3
2 cells
and of more mature pSTAT-5
+CD25
+foxp3
+ cells during early life
of mice, though. If one takes into account the positive effect of
pSTAT-5 on foxp3 expression [27,28], thus, this result suggests
that pSTAT-5
+CD25
+foxp3
2 cells might represent the precursors
of CD25
+foxp3
+ cells. Indeed, it has been shown in two
independent settings, that only a fraction of CD25
+foxp3
2 cells
gave rise to CD25
+foxp3
+ cells [28,30] and in proportions that are
consistent with the frequency of pSTAT-5
+ cells that we report
here. Equal numbers of both subsets would suggest that transition
from one to another might proceed without cell division, at least at
this age. A direct demonstration of this hypothesis will await the
technical possibility to sort out live pSTAT-5
+ cells.
The CD25
+foxp3
+ cells expressed the highest levels of CD122
and had the highest proportions of pSTAT-5
+ cells compared to
other subsets ex vivo. In contrast to CD25
+foxp3
+ mature nTreg
Figure 4. Enhanced selection of Mls-1
a–specific T cells into the regulatory lineage in the thymus of C57BL/66DBA/2 F1 neonates. (A)
Representative flow cytometry analysis of CD25 and foxp3 expression in BV6
+ or BV6
2 cells among CD4
+CD8
2 thymocytes of a F1 mouse at day 3
after birth. (B–E) Frequencies and absolute numbers of CD25
+foxp3
+ (B–C) or CD25
+foxp3
2 cells (D–E) were determined in CD4
+CD8
2 cells within
the indicated TCR-expressing cells (BV6, BV11, BV8.1/8.2) from 3 to 21 mice at the indicated age after birth in B6D2 mice. Results shown are compiled
from 17 independent experiments.
doi:10.1371/journal.pone.0019038.g004
Table 1. Self-specific nTreg are not enriched in pSTAT-5
+
cells
a).
CD25
2foxp3
2 CD25
2foxp3
+ CD25
+foxp3
2 CD25
+foxp3
+
BV6
2 1.461.0 10.864.25 7.765.0 31.962.0
BV6
+ 1.560.9 11.8610.5 3.662,7 32,767,5
a)Results shown are the percentages of pSTAT-5
+ cells in BV6
+ and BV6
2
CD4
+CD8
2 cells (rows) within cells of the indicated phenotype (columns) in
the thymus of C57BL/66DBA/2 mice at day 3 after birth. Results are compiled
from 2 independent experiments from 6 mice.
doi:10.1371/journal.pone.0019038.t001
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+foxp3
2 subset expressed low levels of CD122 and
exhibited low levels of STAT-5 activation ex vivo. Moreover, IL-2/
IL-15 induced pSTAT-5 preferentially in CD122
hi foxp3
+/lo cells
rather than in CD25
hi cells in vitro and presumably in vivo. In the
same line, CD25
2foxp3
lo cells activated STAT-5 at greater levels
than CD25
+foxp3
2 cells upon in vitro stimulation with IL-2 and/or
IL-15 and had higher CD122 expression levels than
CD25
+foxp3
2 cells. Thus, STAT-5 activation ex vivo and in vitro
was associated with CD122 and foxp3 rather than with CD25
expression. What could explain this result? Foxp3 itself might be
responsible for the enhanced activation of the IL-2/IL-15 signaling
pathway in CD122
+ cells through repression of SOCS-1 and
SOCS-3 expression, known inhibitors of STAT-5 activation
[31,32]. Another possibility is that foxp3 might confer higher
susceptibility to IL-2 through a direct effect on CD122 expression.
However, foxp3 is not reported to regulate expression of CD122, in
contrast to CD25 [33,34]. In any case, our results question the
assumption that CD25 expression by itself predicts susceptibility to
IL-2 signaling. Our results confirm in normal mice what was
observed in genetically deficient mice, i.e. the more important role
of CD122 compared to CD25 in regulating foxp3 expression in the
thymus [20,21,22,23].
Interestingly, CD25
2foxp3
lo cells exhibited low levels of
pSTAT-5 ex vivo but that was not due to a lower sensitivity
towards IL-2 since most of the cells were able to activate pSTAT-5
in vitro upon IL-2 stimulation due to a high expression level of
CD122. Thus, these cells might be in contact with limited amount
of IL-2 in vivo. The simultaneous appearance of CD25
2foxp3
lo and
CD25
+foxp3
+ cells during ontogeny, as shown here, and in foxp3-
GFP transgenic neonates [2], suggest that these two populations
might somehow be inter-related. This hypothesis is further
supported by a great deal of homology in their phenotype [2].
Another experimental evidence in favor of an intimate relationship
between CD25
2foxp3
lo and CD25
+foxp3
+ cells comes from the
observation that CD25
+foxp3
+ cells may convert into CD25
2fox-
p3
lo cells upon limiting amount of IL-2 in vivo [35], which is known
to directly regulate CD25 and foxp3 expression.
The role of endogenous Sags in shaping the T cell repertoire has
fueled many reports [36], including the first detailed description of
negative selection in the thymus as a tolerogenic process [37].
Likewise, early studies with endogenous [38] or exogenous [39]
Sags reported that Sag-specific T cells were enriched in CD25
+ T
cells, without information on foxp3 expression, unknown at that
time. More recently, Ribot et al have shown that endogenous Sags
expressed by thymic epithelium efficiently select Sag-specific
foxp3
+ T cells in irradiated bone marrow chimeras [40]. From
the results described above, one might have predicted that
physiological expression of endogenous Sags would have resulted
in the selection of a higher frequency of Sag-specific nTreg cells.
Nevertheless, we show here for the first time to our knowledge that
expression of an endogenous Sag result in enhanced selection of
Sag-specific regulatory T cells early in life. Although selection of
antigen-specific regulatory T cells in the thymus upon recognition
of the cognate antigen in TCR transgenic mice is a well-
established result, our data represent one of the few examples
showing enhanced selection of foxp3
+ cells due to expression of an
endogenous self-antigen in the polyclonal repertoire of normal
mice. This enhanced selection of self-specific foxp3
+ T cells will
certainly help to decipher signaling events affecting this population
during their differentiation.
In that regard, among cells that were committed to the
regulatory lineage (i.e. CD25
+foxp3
2 and CD25
+foxp3
+ cells),
we observed that expression of pSTAT-5 was found in similar
proportions in BV6
+ cells and in BV6
2 cells, showing that
pSTAT-5 expression was not restricted to Sag-specific cells but
rather affected the nTreg population as a whole. Thus, our results
confirm that the TCR signal is the prime factor in shaping the T
cell repertoire of foxp3
+ cells. The ensuing cytokine signal,
mediated by IL-2/STAT-5 is independent of the TCR specificity
and is probably necessary to ‘‘secure’’ foxp3 expression (although
numerous foxp3
+ cells did not expressed detectable levels of
pSTAT-5 by flow cytometry). Because STAT-5 functions as a
inducer of Bcl-2 and Bcl-xL [41], which are crucial anti-apoptotic
molecules, STAT-5 may also be involved in the survival of some
thymocytes recognizing self-antigens. This signal may allow for a
sufficient amount of time for the cells to up-regulate foxp3 under
the influences of additional signals, such as TCR-induced
CARMA-1 leading to c-rel activation [42]. In that respect, it has
been suggested that a Bcl-2 transgene can rescue foxp3 expression
in STAT-5-KO mice (unpublished observations cited in [9]) but
not in CARMA-1 [10,11] or c-rel-KO mice [42], demonstrating
that STAT-5 and foxp3 expression are not absolutely intertwined.
It can then be deduced that STAT-5 activation might be more
important for promoting survival of autoreactive nTreg cells than
to directly induce foxp3 expression in the murine thymus.
Supporting Information
Figure S1 STAT5 and pSTAT-5 stainings in CD4
+CD8
2
murine thymocytes. Representative flow cytometry analysis of
phosphoryled STAT-5 (pSTAT-5) vs. foxp3 expression in (A)
freshly isolated C57BL/6 thymocytes ex vivo,o r( B) in splenocytes
stimulated 30 min. with IL-2 in vitro with or without pre-
incubation with a pSTAT-5 blocking peptide spanning the Y694
of STAT-5. Similar results were obtained in an additional
independent experiment. (C) Shown is the Median Fluorescence
Intensity (MFI) of pSTAT5 in pSTAT5+ cells within the indicated
CD4+ subsets in the thymus of adult C57BL/6 mice. Each dot
corresponds to a single mouse. (D) Shown is the Median
Fluorescence Intensity (MFI) of STAT5 within the indicated
CD4+ subsets in the thymus of a single C57BL/6 mouse
determined in triplicates.
(TIFF)
Figure S2 Evolution of the T cell repertoire during
ontogeny of C57BL/66DBA/2 and C57BL/6 mice. (A) Left
panel: gate defining CD4
+CD8
2 cells is shown in the figure. Right
panel: BV6 expression in CD4
+CD8
2 cells of the thymus of a 3-day
old B6D2 neonate. Gate used to determine frequencies of BV6
+
cells is shown in the figure. (B) Frequencies of BV6
+, BV11
+, and
BV8.1/8.2
+ in CD4
+CD8
2 thymocytes determined by flow
cytometry are shown at the indicated days after birth in the
thymus of C57BL/66DBA/2 (B6D2) and C57BL/6 (B6) mice.
Results shown are compiled from 17 independent experiments.
(TIFF)
Figure S3 TCR repertoire of thymic CD4
+CD8
2 cells in
subsets defined by CD25 and foxp3 expression in
C57BL/6 neonates. (A–D) Frequencies and absolute numbers
of CD25
+foxp3
+ cells (A, B) and of CD25
+foxp3
2 cells (C, D)
expressing the indicated TCR in C57BL/6 (B6) mice at the
indicated ages after birth. Results shown are compiled from 17
independent experiments.
(TIFF)
Figure S4 T cell repertoire analysis in CD4
+CD8
2 cells
defined by CD25 and foxp3 expression in C57BL/
66DBA/2 and C57BL/6 neonates. (A–D) Frequencies of
(A,C) CD25
+foxp3
2 or (B, D) CD25
+foxp3
+ cells expressing the
indicated TCR in C57BL/66DBA/2 (B6D2) or C57BL/6 (B6)
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from 17 independent experiments.
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